Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  resveratrol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: CDR0000396464, P30CA046592, CCUM-2004-0535, CCUM-2062, N01-CN-25025-3, NCT00098969
Resveratrol for Patients With Colon Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCI 05-20, 2005-4333, NCT00256334
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2009-00864, CDR0000528296, LRI-6930, N01-CN-25025, CCUM-TASK2B, N01-CN-25025-4, P30CA046592, NCT00433576
Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OCRT07046, Foundation grant, NCT00578396
Resveratrol in Healthy Adult Participants
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00895, 07-0376-04, BIO07-054, CDR0000656389, UAZ06-8-01, P30CA023074, N01CN35158, UARIZ-BIO-07-0376-04, BIO #07-0376-04, NCT00721877
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 13 and over
Sponsor: Other
Protocol IDs: 2010-0276, NCT01201694
Resveratrol in Postmenopausal Women With High Body Mass Index
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02593, CDR0000701405, 10-0653-04, UAZ08-12-01, P30CA023074, N01CN35158, UARIZ-UAZ08-12-01, NCT01370889
Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: CO 10308, R21CA149560, NCT01324089
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-0097, NCT01476592
Start Over